Clinical translational science 2020: Disruptive innovation redefines the discovery-application enterprise

Clinical and Translational Science

Volumn 4, Issue 1, 2011, Pages 69-71

  Waldman, Scott A ^a   Terzic, Andre ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Cures acceleration network; Discovery application enterprise; National center for advancing translational sciences

Indexed keywords

ARTICLE; CLINICAL PRACTICE; COST CONTROL; DISEASE CONTROL; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG TOLERABILITY; HEALTH CARE DELIVERY; INFORMATION DISSEMINATION; MEDICAL PRACTICE; MEDICAL RESEARCH; MEDICINE; MOLECULARLY TARGETED THERAPY; PATIENT EDUCATION; PATIENT SAFETY; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC-PRIVATE PARTNERSHIP; TRANSLATIONAL RESEARCH;

DRUG DISCOVERY; NATIONAL INSTITUTES OF HEALTH (U.S.); ORGANIZATIONAL INNOVATION; TRANSLATIONAL RESEARCH; UNITED STATES;

EID: 79951923449     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2011.00261.x     Document Type: Article

References (20)

1. Waldman SA, Terzic A. Clinical and translational science: from bench-bedside to global village. Clin Transl Sci. 2010; 3: 254-257.
2. Feero WG, Guttmacher AE, Collins FS. Genomic medicine-an updated primer. N Engl J Med. 2010; 362: 2001-2011.
3. Waldman SA, Kraft WK, Nelson TJ, Terzic A. Experimental therapeutics: a paradigm for personalized medicine. Clin Transl Sci. 2009; 2: 436-438.
4. Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med. 2010; 363: 301-304.
5. Waldman SA, Terzic A. Molecular therapeutics from knowledge to delivery. Clin Pharmacol Ther. 2010; 87: 619-623.
6. Kaiser J. National Institutes of Health. A government niche for translational medicine and drug development. Science 2010; 330: 1462-1463.
7. Nabel EG. On board with the Cures Acceleration Network. Sci Transl Med. 2010; 2: 32ed2.
8. Butler D. Translational research: crossing the valley of death. Nature. 2008; 453: 840-842.
9. Reis SE, Berglund L, Bernard GR, Califf RM, Fitzgerald GA, Johnson PC. National Clinical and Translational Science Awards Consortium. Reengineering the national clinical and translational research enterprise: the strategic plan of the National Clinical and Translational Science Awards Consortium. Acad Med. 2010; 85: 463-469.
10. Skarke C, FitzGerald GA. Training translators for smart drug discovery. Sci Transl Med. 2010; 2: 26cm12.
11. Bonham AC, Rich EC, Davis DA, Longnecker DE, Heinig SJ. Putting evidence to work: an expanded research agenda for academic medicine in the era of health care reform. Acad Med. 2010; 85: 1551-1553.
12. Waldman SA, Terzic A. Translational medicine in the era of health care reform. Clin Transl Sci. 2009; 2: 96-97.
13. Clancy C, Collins FS. Patient-centered outcomes research institute: the intersection of science and health care. Sci Transl Med. 2010; 2: 37cm18.
14. Waldman SA, Terzic A. Molecular therapy drives patient-centric health care paradigms. Clin Transl Sci. 2010; 3: 170-171.
15. Waldman SA, Kraft WK, Nelson TJ, Terzic A. Clinical pharmacology: a paradigm for individualized medicine. Biomark Med. 2009; 3: 679-684.
16. Waldman SA, Terzic A. Molecular diagnostics. At the nexus of individualized medicine, health care delivery, and public policy. Clin Transl Sci. 2009; 2: 6-8.
17. Terzic A, Waldman SA. Translational medicine: path to personalized and public health. Biomark Med. 2010; 4: 787-790.
18. Brook RH. Medical leadership in an increasingly complex world. JAMA. 2010; 304: 465-466.
19. Wadman M. The bridge between lab and clinic. Nature 2010; 468: 877.
20. Collins FS. Proposed National Center for Advancing Translational Sciences 2010.